1. Market Research
  2. > Pathology
Customer Support

Talk to Ahmad

+1 718 618 4302

Industries

  • All
    • Chronic Disease
About 600 reports for Lymphoma (page 1)

Purchase Reports From Reputable Market Research Publishers

Systemic Lupus Erythematosus and Lupus Nephritis: Global Drug Forecast and Market Analysis to 2027

  • $ 10995
  • February 2020
  • 163 pages

R. (2016) ' B CELLS GONE ROGUE: THE INTERSECTION OF DIFFUSE LARGE B CELL LYMPHOMA AND AUTOIMMUNE DISEASE', EXPERT REVIEW OF HEMATOLOGY, ##(##), PP. ##-##.

  • Chronic Disease
  • Genitourinary System Disease
  • Lymphoma
  • Musculoskeletal Disorder
  • Therapy

Pharmaceutical Drug Delivery Market Forecast to 2027 - COVID-19 Impact and Global Analysis by Route of Administration ; Application ; End User, and Geography

  • $ 4550
  • May 2020
  • 197 pages

Pfizer Inc. has received the European Commission (EC) for its Lorviqua for the treatment of adult patients with anaplastic lymphoma kinase (ALK)-positive advanced nonsmall cell lung cancer (NSCLC).

  • Chronic Disease
  • Lymphoma
  • Pharmaceutical
  • Forecast
  • Market Size

Global Auto-Injectors Market (By Application/Indication, Product Type, Usability, Distribution Channels, Region), Key Company Profiles - Forecast to 2025

  • $ 1990
  • August 2019
  • 126 pages

lymphoma, OCREVUS for the treatment of primary progressive MS (PPMS) and relapsing MS (RMS) and other potential anti-CD## therapies pursuant to its collaboration arrangements with Genentech, Inc.

  • Chronic Disease
  • Injectable Delivery
  • Lymphoma
  • World
  • Amgen Inc.

Global Clinical Chemistry Analyzer Market - Opportunities and Forecast (2013-2023)

  • $ 2200
  • March 2019
  • 220 pages

NORTH AMERICA CLINICAL CHEMISTRY ANALYZER MARKET FIGURE ##: NUMBER OF PEOPLE LIVING WITH BLOOD CANCER IN CANADA, 2016 Forms of Blood Cancer Number of Patients Lymphoma ##, ## Leukemia ##, ## Myeloma ##, ## Myelodysplastic Syndromes ##, ## Polycythemia Vera ##, ## Thrombocythemia ##, ## Myelof

  • Chronic Disease
  • Clinical Chemistry
  • In Vitro Diagnostics
  • Lymphoma
  • World

Global Autoimmune Disease Diagnostic Market (By Disease, Tests Type, Regions), Key Company Profiles - Forecast to 2026

  • $ 1890
  • November 2019
  • 137 pages

lymphoma, metabolic disorders, obesity, occult blood testing, ophthalmology, osteoporosis, pancreatitis, respiratory disorders, rheumatoid arthritis, sepsis, sexually transmitted infections, skin cancer, transplantation, tuberculosis, urinary tract infections, and West Nile virus diseases.

  • Autoimmune Disease
  • Chronic Disease
  • Diagnostics
  • Lymphoma
  • World

Global Cell Expansion Market: Analysis By Product Type, Cell Type, By Application, By Region, By Country : Opportunities and Forecast – By Application, By Region, By Country

  • $ 2400
  • June 2019
  • 284 pages

Lymphoma ##, ## Leukemia ##, ## Myeloma ##, ## Myelodysplastic Syndromes ##, ## Polycythemia Vera ##, ## Thrombocythemia ##, ## Myelofibrosis ##, ## Forms of Blood Cancer Number of Patients Source: LLS Canada FIGURE ##: NUMBER OF BLOOD CANCER CASES IN UNITED STATES, 2018 (c) Azoth Analytics To

  • Chronic Disease
  • Healthcare
  • Insulin Delivery
  • Lymphoma
  • World

Global Compounding Pharmacies Market - Opportunities and Forecast (2014-2024)

  • $ 2400
  • July 2019
  • 260 pages

Compounding Pharmacies Market: World Market Analysis By Product Type, By Therapeutic Area, By End User, By Region, By Country (2019 Edition): Forecast to 2024 Dermatology and Others) India, Brazil and Mexico.

  • Chronic Disease
  • Lymphoma
  • Pharmacy
  • World
  • Market Size

Global Nuclear Medicine Market - Opportunities and Forecast (2013-2023)

  • $ 2400
  • January 2019
  • 244 pages

lymphoma where as samarium-##-EDTMP, and strontium-##-chloride for palliation of bone metastases.

  • Chronic Disease
  • Lymphoma
  • Pathology
  • World
  • Cardinal Health, Inc.

Global Regenerative Medicine Market - Opportunities and Forecast

  • $ 2400
  • August 2019
  • 326 pages

This strategic acquisition will further promote Gilead as an industry leader in refractory large B-cell lymphoma after two or more lines of therapy.

  • Biopharmaceutical
  • Chronic Disease
  • Lymphoma
  • Regenerative Medicine
  • Market Size

Wearable Injectors Market Forecast to 2027 - COVID-19 Impact and Global Analysis by Type ; Application ; End User ; and Geography

  • $ 4550
  • June 2020
  • 184 pages

The wearable injectors market was valued at US$ 5,791.23 million in 2019 and is projected to reach US$ 13,880.88 million by 2027; it is expected to grow at a CAGR of 11.6% during 2020-2027. Wearable injectors ...

  • Autoimmune Disease
  • Chronic Disease
  • Diabetes
  • Lymphoma
  • Forecast

North America Pharmaceutical Drug Delivery Market Forecast to 2027 - COVID-19 Impact and Regional Analysis By  Route of Administration ; Application ; End User ; and Country

  • $ 3000
  • June 2020
  • 145 pages

Pfizer Inc. has received the European Commission (EC) for its Lorviqua for the treatment of adult patients with anaplastic lymphoma kinase (ALK)-positive advanced non-small cell lung cancer (NSCLC).

  • Chronic Disease
  • Lymphoma
  • Pharmaceutical
  • North America
  • United States

Global Sterile Injectables Market – Analysis By Molecule Type, Drug Type, Indication, Distribution Channel, By Region, By Country (2018 Edition): Forecast to 2023 - Molecule Type, Drug Type, Indication, Channel

  • $ 2400
  • June 2018
  • 240 pages

lymphoma Diffuse large B-cell lymphoma Diffuse large B-cell lymphoma Pfizer Utomilumab Human IgG## CD## Phase ## Hoffmann-La Roche Polatuzumab vedotin Humanized IgG## ADC CD##b Phase ## Viventia Bio Oportuzumab monatox Humanized scFv immunotoxin EpCAM Phase ## Bladder cancer S

  • Chronic Disease
  • Endocrine Disease
  • Lymphoma
  • World
  • Baxter International Inc.

Europe Pharmaceutical Drug Delivery Market Forecast to 2027 - Covid-19 Impact and Regional Analysis By  Route of Administration ; Application ; End User ; and Country

  • $ 3000
  • June 2020
  • 145 pages

Novartis has received the US Food and Drug Administration (FDA) approved for the Zykadia, which is used for the treatment of patients with advanced non-small cell lung cancer (NSCLC) whose tumors are anaplastic lymphoma kinase (ALK)positive.

  • Chronic Disease
  • Lymphoma
  • Pharmaceutical
  • Forecast
  • GlaxoSmithKline plc

Clinical Nutrition Market - Global Outlook and Forecast 2020-2025

  • $ 3500
  • July 2020
  • 306 pages

The most common categories of cancers in children include leukemias, brain cancers, lymphomas, and solid tumors such as neuroblastoma and Wilms' tumor.

  • Chronic Disease
  • Clinical Nutrition
  • Lymphoma
  • Pharmaceutical
  • World

Vascular Access Device Market: World Market - Opportunities and Forecast (2014-2024)

  • $ 2400
  • July 2019
  • 300 pages

Executive Summary A comprehensive research report created through extensive primary research (inputs from industry experts, companies, stakeholders) and secondary research, the report aims to present the ...

  • Chronic Disease
  • Drug Delivery
  • Injectable Delivery
  • Lymphoma
  • World

Potential "Pipeline Disruptors" - New Products That Will Drive The Future Pharmaceutical Market

  • $ 4200
  • May 2017
  • 120 pages

(% market share) CHAPTER ##: PIPELINE DISRUPTORS: LYMPHOMA MARKET OPPORTUNITY Non-Hodgkin' s Lymphoma Table ##-##: Classification of Non-Hodgkin' s Lymphomas Hodgkin' s Lymphoma Figure ##-##: Global Incidence and Mortality of Lymphoma by Country, 2012* THE HEAVY HITT

  • Chronic Disease
  • Lymphoma
  • Monoclonal Antibody
  • Pathology
  • Targeted Therapy

Vanderbilt University Medical Center - Pharmaceuticals & Healthcare - Deals and Alliances Profile

  • $ 250
  • September 2018
  • 56 pages

The institute' s target therapy areas include leukemia, lymphoma, blood cancer, lung cancer, breast cancer, colorectal cancer and skin cancer, among others.

  • Ambulatory Care
  • Chronic Disease
  • Lymphoma
  • Therapy
  • United States

Pharmaceutical Drugs Global Market Report 2018

  • $ 8000
  • March 2018
  • 455 pages

Its importance results from the large population of cancer patients suffering from various types of blood cancers such as leukemia, lymphoma, and myeloma.

  • Chronic Disease
  • Healthcare
  • Lymphoma
  • Pharmaceutical
  • Market Size

Global Diabetes Drugs Market to 2023 - A Diversifying Treatment Landscape as GLP-1 Receptor Agonists and SGLT-2 Inhibitors Gain Ground Following Landmark Cardiac Outcomes

  • $ 4995
  • September 2017
  • 137 pages

Numerous intracellular substrates such as insulin receptor substrate (IRS) proteins, casitas B-lineage lymphoma (CBL), adapter proteins with a pleckstrin homology (PH) and Src Homology ## (SH##) domain and GRB##-associated-binding protein ## (GAB##) are activated upon binding of the insulin rece

  • Chronic Disease
  • Clinical Trial
  • Diabetes
  • Insulin
  • Lymphoma

Global Surgical Ablation Market 2017-2021

  • $ 2500
  • June 2017
  • 93 pages

There are distinct types of cancers such as skin, breast, colorectal, lung, lymphoma, and prostate cancers.

  • Chronic Disease
  • Health Services
  • Lymphoma
  • Boston Scientific Corporation
  • Medtronic, Inc.
View report >

Asthma Statistics in the UK

  • January 2017
  • 15 pages

Cancer Chart ##. ## shows the most common cancers for this age group are lymphomas, including cancer of the lymph system, Hodgkin Disease and non-Hodgkin Lymphoma, followed by carcinomas (malignant tumours on the surface or lining of a body organ).

  • Asthma
  • Chronic Disease
  • Lymphoma
  • United Kingdom
  • Diabetes UK

Reportlinker.com © Copyright 2020. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.

Make sure you don’t miss any news and follow us on